KateClancyMD

Otolaryngology (ENT) • Lorain, OH

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery, Head & Neck Plastic Surgery

Physician

Join to view full profile

Dr. Clancy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Clancy's full profile

Already have an account?

Office
3600 Kolbe Rd
Ste 206
Lorain, OH 44053
Phone+1 440-222-4140

Fax+1 440-222-4141

Education & Training

UPMC Medical EducationFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2022 - 2023
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 2017 - 2022
Case Western Reserve University School of MedicineClass of 2017

Certifications & Licensure

OH State Medical License 2017 - 2025
PA State Medical License 2022 - 2024
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Publications & Presentations

PubMed

3 citations
Prognostic significance of time trends in treatment of head and neck squamous cell carcinoma.
Divya Balchander, Khaled Shorbaji, Claudia I Cabrera, David Hoying, Kate Clancy
American Journal of Otolaryngology. 2023-07-05
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomas.
Chelsea S Hamill, Richard Grant Muller, Kate Clancy, Brandon Vu, Shanying Gui
Laryngoscope Investigative Otolaryngology. 2022-08-01
6 citations
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients.
Kate Clancy, Chelsea S. Hamill, W. Quinn O’Neill, Brandon Vu, Jason Thuener
Cancers. 2021-09-28